Artículos por temáticas

Gait as a biomarker? Accelerometers reveal that reduced movement quality while walking is associated with Parkinson's disease, ageing and fall risk.

Brodie MA, Lovell NH, Canning CG, Menz HB, Delbaere K, Redmond SJ, Latt M, Sturnieks DL, Menant J, Smith ST, Lord SR.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:5968-71. doi: 10.1109/EMBC.2014.6944988.

Puerarin protects dopaminergic neurons in Parkinson's disease models.

Zhang X, Xiong J, Liu S, Wang L, Huang J, Liu L, Yang J, Zhang G, Guo K, Zhang Z, Wu P, Wang D, Lin Z, Xiong N, Wang T.

Neuroscience. 2014 Nov 7;280:88-98. doi: 10.1016/j.neuroscience.2014.08.052.

Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?

Guidez D, Behnke S, Halmer R, Dillmann U, Faßbender K, Kirsch CM, Hellwig D, Spiegel J.

J Neurol. 2014 Jan;261(1):45-51. doi: 10.1007/s00415-013-7135-4.

Increasing speed to improve arm movement and standing postural control in Parkinson's disease patients when catching virtual moving balls.

Su KJ, Hwang WJ, Wu CY, Fang JJ, Leong IF, Ma HI.

Gait Posture. 2014 Jan;39(1):65-9. doi: 10.1016/j.gaitpost.2013.05.029.

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Herz DM, Siebner HR, Hulme OJ, Florin E, Christensen MS, Timmermann L.

Neuroimage. 2014 Apr 15;90:15-23. doi: 10.1016/j.neuroimage.2013.11.023.

Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.

Ton TG, Biggs ML, Comer D, Curtis L, Hu SC, Thacker EL, Searles Nielsen S, Delaney JA, Landsittel D, Longstreth WT Jr, Checkoway H, Jain S.

Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):119-27. doi: 10.1002/pds.3552.

Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?

Hung AY, Schwarzschild MA.

Neurotherapeutics. 2014 Jan;11(1):34-46. doi: 10.1007/s13311-013-0239-9. Review.

Non-motor symptoms of Parkinson's disease A review…from the past.

Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P.

J Neurol Sci. 2014 Mar 15;338(1-2):30-3. doi: 10.1016/j.jns.2014.01.002. Review.

Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.

Wang XY, Kang WY, Yang Q, Zhang LY, Chen SD, Liu J.

PLoS One. 2014 Feb 27;9(2):e89353. doi: 10.1371/journal.pone.0089353.

Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease.

Mermillod M, Mondillon L, Rieu I, Devaux D, Chambres P, Auxiette C, Dalens H, Coulangeon LM, Jalenques I, Durif F.

J Parkinsons Dis. 2014;4(1):97-110. doi: 10.3233/JPD-130256.

Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Sääksjärvi K, Knekt P, Männistö S, Lyytinen J, Jääskeläinen T, Kanerva N, Heliövaara M.

Eur J Epidemiol. 2014 Apr;29(4):285-92. doi: 10.1007/s10654-014-9887-2.

Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease: a questionnaire-based study.

Mahale R, Yadav R, Pal PK.

Sleep Med. 2014 Jun;15(6):642-6. doi: 10.1016/j.sleep.2014.01.022.

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.

Schlaudraff F, Gründemann J, Fauler M, Dragicevic E, Hardy J, Liss B.

Neurobiol Aging. 2014 Oct;35(10):2302-15. doi: 10.1016/j.neurobiolaging.2014.03.016.

Effects of antidromic and orthodromic activation of STN afferent axons during DBS in Parkinson's disease: a simulation study.

Kang G, Lowery MM.

Front Comput Neurosci. 2014 Mar 19;8:32. doi: 10.3389/fncom.2014.00032.

Pulsion severity showed a good correlation with cognitive function in Parkinson's disease.

Kurata T, Hatanaka N, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Abe K.

Neurol Res. 2014 Nov;36(11):962-7. doi: 10.1179/1743132814Y.0000000384.